Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
StemVacs-V by Res Nova Bio for Metastatic Breast Cancer: Likelihood of Approval
StemVacs-V is under clinical development by Res Nova Bio and currently in Phase II for Metastatic Breast Cancer. According to...